WaferGen to Launch Early Access Program for Single-Cell Applications of SmartChip Technology | GenomeWeb

NEW YORK (GenomeWeb) – WaferGen will create an early access program to develop single-cell genomics applications for its SmartChip technology, which the firm hopes will become the focal point of its business.

"We envision that this would be our flagship product," WaferGen CEO Ivan Trifunovich told GenomeWeb. "Increased throughput and reduced costs will be a huge value proposition. This will probably be our most important product and we are putting lots of resources and R&D behind it."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.